Cytokinetics reported $24.43M in Trade Debtors for its fiscal quarter ending in June of 2026.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 178.32M 11.98M Sep/2026
Amgen USD 10.35B 126M Sep/2026
Bayer EUR 17.41B 1.29B Sep/2026
Biogen USD 2.38B 15.8M Sep/2026
Brainstorm Cell Therapeutics USD 122K 36K Mar/2026
Bristol-Myers Squibb USD 12.85B 976M Sep/2026
Capricor Therapeutics USD 59K 0 Dec/2025
Cytokinetics USD 24.43M 17.6M Jun/2026
Eisai JPY 237.44B 15.69B Sep/2026
Eli Lilly USD 23.48B 2.3B Jun/2026
Exelixis USD 328.47M 6.25M Sep/2026
Geron USD 53.5M 9.41M Jun/2026
Halozyme Therapeutics USD 518.59M 65.26M Sep/2026
Ionis Pharmaceuticals USD 88M 29.15M Sep/2026
Ligand Pharmaceuticals USD 69.92M 15.12M Jun/2026
Merck USD 12.56B 354M Jun/2026
Novartis USD 9.96B 109M Sep/2026
Pfizer USD 17.57B 1.38B Sep/2026
Regeneron Pharmaceuticals USD 6.57B 834.4M Jun/2026
Roche Holding CHF 13.34B 1.44B Jun/2026
Sanofi EUR 326M 166M Sep/2026